Tyrosine phosphatase PTP-MEG2 negatively regulates vascular endothelial growth factor receptor signaling and function in endothelial cells

被引:19
|
作者
Hao, Qin [1 ]
Samten, Buka [2 ]
Ji, Hong-Long [1 ]
Zhao, Z. Joe [3 ]
Tang, Hua [1 ]
机构
[1] Univ Texas Hlth Sci Ctr Tyler, Dept Biochem, Tyler, TX 75708 USA
[2] Univ Texas Hlth Sci Ctr Tyler, Dept Microbiol & Immunol, Tyler, TX 75708 USA
[3] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA
来源
关键词
protein tyrosine phosphatase; endothelial cells; vascular endothelial growth factor receptor 2; Janus kinase 1; interleukin-6; PROTEIN; ACTIVATION; KINASE; MEG2; POLYPHOSPHOINOSITIDES; PHOSPHORYLATION;
D O I
10.1152/ajpcell.00415.2011
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Hao Q, Samten B, Ji HL, Zhao ZJ, Tang H. Tyrosine phosphatase PTP-MEG2 negatively regulates vascular endothelial growth factor receptor signaling and function in endothelial cells. Am J Physiol Cell Physiol 303: C548-C553, 2012. First published July 3, 2012; doi:10.1152/ajpcell.00415.2011.-Protein tyrosine phosphorylation is a fundamental mechanism for diverse physiological processes, which is regulated by protein tyrosine kinases and protein tyrosine phosphatases (PTPs). In this study, we searched for protein substrates of PTP-MEG2 (also called PTPN9), a nonreceptor PTP, and investigated its function in endothelial cells (ECs). By using a PTP-MEG2 substrate-trapping DA mutant, we found that a couple of tyrosine-phosphorylated proteins were associated with the DA mutant but not wild-type PTP-MEG2 and that the association was enhanced by vascular endothelial growth factor (VEGF) in ECs. We further found that VEGF receptor 2 (VEGFR2) was coimmunopricipitated with the DA mutant but not wild-type PTP-MEG2. The VEGF-induced phosphorylation of VEGFR2 on Tyr1175, a critical autophosphorylation site for VEGFR2 signaling, was inhibited 70% by overexpression of wild-type PTP-MEG2 but was enhanced (2.2-fold) by the DA mutant of PTP-MEG2. We also found that PTP-MEG2 DA mutant preferentially associated with Janus kinase 1 (JAK1) but not with other JAK kinases (Tyk2 and JAK2) present in ECs and regulated JAK1 tyrosine phosphorylation. Lastly, the VEGF-induced signal transduction and the production of interleukin (IL)-6 were significantly enhanced by PTP-MEG2 knockdown in ECs, whereas the VEGF-induced IL-6 production was inhibited 50% by PTP-MEG2 overexpression. Thus we have indentified VEGFR2 as a PTP-MEG2 substrate, and our findings indicate that PTP-MEG2 is a negative regulator of VEGFR2 signaling and function in ECs.
引用
收藏
页码:C548 / C553
页数:6
相关论文
共 50 条
  • [31] Vascular endothelial growth factor induces Shc association with vascular endothelial cadherin - A potential feedback mechanism to control vascular endothelial growth factor receptor-2 signaling
    Zanetti, A
    Lampugnani, MG
    Balconi, G
    Breviario, F
    Corada, M
    Lanfrancone, L
    Dejana, E
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (04) : 617 - 622
  • [32] Role of vascular endothelial growth factor receptor 1 and vascular endothelial growth factor receptor 2 in the vasodilator response to vascular endothelial growth factor in the neonatal piglet lung
    Janvier, A
    Nadeau, S
    Baribeau, J
    Perreault, T
    CRITICAL CARE MEDICINE, 2005, 33 (04) : 860 - 866
  • [33] Notch Signaling Negatively Regulates Vascular Endothelial Cell Senescence
    Yoshida, Yohko
    Minamino, Tohru
    CIRCULATION RESEARCH, 2012, 111 (04)
  • [34] Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema
    Kasahara, Y
    Tuder, RM
    Cool, CD
    Lynch, DA
    Flores, SC
    Voelkel, NF
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (03) : 737 - 744
  • [35] Neuro-oncological Ventral Antigen 2 Regulates Splicing of Vascular Endothelial Growth Factor Receptor 1 and Is Required for Endothelial Function
    Veerle Kremer
    Jetta J. Oppelaar
    Theresa Gimbel
    Susanne Koziarek
    Wessel Ganzevoort
    Mariëlle G. van Pampus
    Bert-Jan van den Born
    Liffert Vogt
    Christianne de Groot
    Reinier A. Boon
    Reproductive Sciences, 2023, 30 : 678 - 689
  • [36] Neuro-oncological Ventral Antigen 2 Regulates Splicing of Vascular Endothelial Growth Factor Receptor 1 and Is Required for Endothelial Function
    Kremer, Veerle
    Oppelaar, Jetta J.
    Gimbel, Theresa
    Koziarek, Susanne
    Ganzevoort, Wessel
    van Pampus, Marielle G.
    Van den Born, Bert-Jan
    Vogt, Liffert
    de Groot, Christianne
    Boon, Reinier A.
    REPRODUCTIVE SCIENCES, 2023, 30 (02) : 678 - 689
  • [37] Neuropathy with vascular endothelial growth factor receptor tyrosine kinase inhibitors
    Roy, Bhaskar
    Das, Avash
    Ashish, Kumar
    Bandyopadhyay, Dhrubajyoti
    Maiti, Abhishek
    Chakraborty, Sandipan
    Stone, Martha E.
    Philpotts, Lisa Liang
    Nowak, Richard J.
    Patwa, Huned S.
    NEUROLOGY, 2019, 93 (02) : E143 - E148
  • [38] Pancreatitis with vascular endothelial growth factor receptor tyrosine kinase inhibitors
    Ghatalia, Pooja
    Morgan, Charity J.
    Choueiri, Toni K.
    Rocha, Pedro
    Naik, Gurudatta
    Sonpavde, Guru
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 94 (01) : 136 - 145
  • [39] Vascular endothelial growth factor regulates both apoptosis and angiogenesis of choriocapillaris endothelial cells
    Li, WY
    He, ZH
    Li, Y
    Yanoff, M
    MICROVASCULAR RESEARCH, 2000, 59 (02) : 286 - 289
  • [40] Long Noncoding RNA MEG3 Negatively Regulates Proliferation and Angiogenesis in Vascular Endothelial Cells
    He, Chao
    Yang, Wei
    Yang, Jun
    Ding, Jiawang
    Li, Song
    Wu, Hui
    Zhou, Fei
    Jiang, Yurong
    Teng, Lin
    Yang, Jian
    DNA AND CELL BIOLOGY, 2017, 36 (06) : 475 - 481